Aclarion, Inc. (NASDAQ:ACONW) Sees Significant Growth in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) was the target of a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 604 shares, a growth of 504.0% from the May 14th total of 100 shares. Based on an average daily volume of 16,125 shares, the short-interest ratio is currently 0.0 days.

Aclarion Stock Down 9.2%

Shares of ACONW stock traded down $0.00 during mid-day trading on Friday, reaching $0.03. The stock had a trading volume of 11,245 shares, compared to its average volume of 13,261. The business’s fifty day moving average is $0.03 and its 200-day moving average is $0.04. Aclarion has a 1-year low of $0.02 and a 1-year high of $0.23.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.